The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
about
Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospectsThe biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patientsRole of lipotoxicity in endothelial dysfunctionTherapeutic approach in the improvement of endothelial dysfunction: the current state of the artIdentification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by statins and antimalarial agentsDNA methylation is altered in maternal blood vessels of women with preeclampsia.A PPARγ-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis.A Novel Cytosolic Isoform of Mitochondrial Trans-2-Enoyl-CoA Reductase Enhances Peroxisome Proliferator-Activated Receptor α Activity.Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation.Nicotinic acid receptor GPR109A is down-regulated in human macrophage-derived foam cells.Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway.Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet.The Interaction of FABP with Kapα.Regulation of Nox enzymes expression in vascular pathophysiology: Focusing on transcription factors and epigenetic mechanisms.New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury.Suppression of IL-8 production in gastric epithelial cells by MUC1 mucin and peroxisome proliferator-associated receptor-γ.The metabolic control of schistosome egg production.Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Gender and racial/ethnic differences in the associations of urinary phthalate metabolites with markers of diabetes risk: National Health and Nutrition Examination Survey 2001-2008.Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.Helicobacter pylori and Gastric Inflammation: Role of MUC1 MucinThe peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.High-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPARα and PPARβ/δ.Electrospinning of Bioactive Wound-Healing Nets.Loss of PPARγ expression by fibroblasts enhances dermal wound closure.Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis.Aorta macrophage inflammatory and epigenetic changes in a murine model of obstructive sleep apnea: Potential role of CD36.Obesity gene atlas in mammals.Novel 9-cis/all-trans β-carotene isomerases from plastidic oil bodies in Dunaliella bardawil catalyze the conversion of all-trans to 9-cis β-carotene.Electrospun bioactive mats enriched with Ca-polyphosphate/retinol nanospheres as potential wound dressing.Metabolic syndrome, circulating RBP4, testosterone, and SHBG predict weight regain at 6 months after weight loss in men.Xanthophylls increased HDLC level and nuclear factor PPARγ, RXRγ and RARα expression in hens and chicks.Association of circadian genes with diurnal blood pressure changes and non-dipper essential hypertension: a genetic association with young-onset hypertension.Coumestrol modulates Akt and Wnt/β-catenin signaling during the attenuation of adipogenesis.
P2860
Q26829098-10B7DC20-EB04-451B-9CF6-28F8EDEB7A26Q26862601-BDFC40E5-C9DF-4AFC-873E-49E10E7ADDDCQ27000731-33A374DF-F94B-43DA-9D63-260045DD3B4BQ27027533-61F12BE2-053A-4885-829F-2225E2D2EA2AQ27302392-2311D53E-5E14-4DCD-8F0B-A3629D95602AQ33714783-7DC2559C-8873-4198-AA36-854DC8A7A4C5Q33746963-29BA8773-7B7E-4D50-B458-4C4E589E1E61Q33879954-F2FE7E6B-6BA3-4F65-9C24-47970AA33830Q34315697-CEC90BC4-E97F-4B1B-9D48-BADB42A8F6DDQ34712851-16686976-90AD-437E-B237-F3105C28451FQ35163413-7D0A598F-0C95-4157-B2DD-57754FB35173Q35223489-83935175-62E4-4F4D-84DB-A2073D519922Q35716907-FA1DD23F-D3D0-47C6-856F-A7B456EBEFF6Q35748676-332DB051-A173-44FB-92B0-60F363E5D6EDQ35849697-02AE5D0F-4857-4436-A670-52187FCFB55AQ35864188-6B26AD42-28A5-4381-B93B-0DF30A344791Q36309498-F302EB8F-D971-42A9-8302-64587AD41F8FQ36902948-A645D007-4446-4137-9785-03E232CD30BCQ37254899-F2FA6188-4D1B-463F-92FE-D812B0E57A68Q37580349-5813C03B-0E3A-454F-94D4-EF3F8BF75D33Q37734673-C01FA9E1-F638-4467-9986-4F03CA7CE246Q38106038-70D8AA56-0E17-48D1-95EE-647738CD6EF5Q38273378-E064A4A2-0580-4AC2-AB6F-B3A1A8A04116Q38546242-612C2CAB-72BA-4443-B3A9-991A4064CCD1Q38674739-8A0C0D1C-84A7-494E-82CF-BA6AE3C3DE85Q38674742-82D103E4-48E5-48C8-931A-4D500713C095Q38905577-D7702952-0175-4A98-9B3C-C3399E0C4428Q39151188-B3CF5166-BA9D-4844-87B3-E0E344701AE6Q39629362-838591BC-EDDC-40A7-B948-58A7F5E26B45Q41819842-F29355C9-4118-4456-971D-CCBAB04A5BB8Q41832970-2887688B-0422-4E25-9283-A8BE8A9668E2Q41854442-C3621435-FCCC-4005-B5F3-6C5EB13CAC12Q46405297-BAB6E135-8346-46BF-B58F-4C533950AA58Q47144633-2C3F69AA-2AA9-40D9-AB92-5486A3E7D42EQ47254405-5D4860E4-F223-4F70-9BC6-B52F4FBA5850Q47829256-E8F79F91-0ADD-404A-82A8-0A7CF6FF31C4Q48172897-6775A80A-832D-4412-853F-5AEEA9CA8FDAQ50223203-8F3C400B-60E8-4BB4-8E39-FAFFD2A62AF4
P2860
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
@ast
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
@en
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
@nl
type
label
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
@ast
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
@en
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
@nl
prefLabel
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
@ast
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
@en
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
@nl
P1433
P1476
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance
@en
P2093
Jorge Plutzky
P304
P356
10.1161/CIRCRESAHA.110.226860
P407
P577
2011-04-15T00:00:00Z